Dipeptidyl Peptidase-4 inhibitors use in type II diabetic patients in a tertiary hospital

BACKGROUND: In Malaysia, for more than a decade, dipeptidyl peptidase-4 inhibitors (DPP-4i) are among the oral antidiabetic medications used as monotherapy or in combination to manage type II diabetes mellitus (T2DM). These medications are known for the efficacy in glycated haemoglobin (HbA1c) reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mak, Woh Yon, Nagarajah, Jivanraj R., Abdul Halim, Hannah, Ramadas, Anitha, Mohd Pauzi, Zulsairi, Pee, Lay Ting, Jagan, Nirmala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301996/
https://www.ncbi.nlm.nih.gov/pubmed/32566235
http://dx.doi.org/10.1186/s40545-020-00238-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301996/
https://www.ncbi.nlm.nih.gov/pubmed/32566235
http://dx.doi.org/10.1186/s40545-020-00238-y

Ejemplares similares